All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
ARAV / Aravive, Inc.
|
|
|
|
|
|
|
|
OREX / Orexigen Therapeutics, Inc.
|
|
|
|
|
|
|
|
ATRA / Atara Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
GILD / Gilead Sciences, Inc. Call
|
|
|
|
|
|
|
|
BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
FGEN / FibroGen, Inc.
|
|
|
|
|
|
|
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
LIFE / aTyr Pharma, Inc.
|
|
|
|
|
|
|
|
FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
TPST / Tempest Therapeutics, Inc.
|
|
|
|
|
|
|
|
VIVE / Viveve Medical, Inc.
|
|
|
|
|
|
|
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
RGLS / Regulus Therapeutics Inc.
|
|
|
|
|
|
|
|
US88338TAB08 / Innoviva, Inc.
|
|
|
|
|
|
|
|
17K / Self Storage Group ASA
|
|
|
|
|
|
|
|
AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CASC / Cascadian Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
FAST / Fastenal Company
|
|
|
|
|
|
|
|
ASMB / Assembly Biosciences, Inc.
|
|
|
|
|
|
|
|
JNCE / Jounce Therapeutics Inc
|
|
|
|
|
|
|
|
CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
SYRS / Syros Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
NBRV / Nabriva Therapeutics Plc
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CASC / Cascadian Therapeutics, Inc.
|
|
|
|
|
|
|
|
FWP / Forward Pharma A/S - ADR
|
|
|
|
|
|
|
|
WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|